ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q1SCImago #5,119Review JournalSubscription

Aids Reviews

Abbreviation (ISO):AIDS REV
•
Identifier (ISSN):1139-6121(Print)/1698-6997(Online)
•
Publisher:Publicaciones Permanyer
Clarivate IF (2026)
2↓ -0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Aids Reviews

WoS Q4
12342.7720182.3620192.2920202.520212.3820222.220231.920242.5202522026
Annual Impact Factor Metric
Current (2026):2
Scopus SJR & RankScopus Q1
0.972
#5,119

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
64

64 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate5.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
16articles/year
0% Gold OA•50% Original Research

Aims & Scope

AIDS Reviews publishes papers reporting original scientific, clinical, epidemiologic and social research which contribute to the overall knowledge of the field of the acquired immunodeficiency syndrome and human retrovirology. Currently, the Journal publishes review articles (usually by invitation, but spontaneous submitted articles will also be considered). Manuscripts submitted to AIDS Reviews will be accepted on the understanding that the authors have not submitted the paper to another journal or published the material elsewhere.

Topics Covered (Recognized by AI)
Medicine94.5%Biology92.8%Immunology85.4%Virology85.1%Genetics75.5%Family medicine75.4%Human immunodeficiency virus (HIV)75.2%Internal medicine64%Virus59.6%Pathology49.9%Chemistry45.1%Biochemistry43.6%Viral load43%Antiretroviral therapy39.7%Gene28.8%Intensive care medicine26.1%Psychology24.8%Environmental health23.1%Psychiatry20.9%Sociology20.8%Pharmacology20.3%Disease20.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q4
Rank149/183
IndexSCIE
JCRSCIE2026

INFECTIOUS DISEASES

Q3
Rank100/141
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q4
Rank146/183
IndexSCIE
JCISCIE2026

INFECTIOUS DISEASES

Q4
Rank109/141
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2
Articles / Year10
Total Citations0
2025
IF2.5
Articles / Year30
Total Citations6
2024
IF1.9
Articles / Year24
Total Citations45
2023
IF2.2
Articles / Year19
Total Citations111
2022
IF2.381
Articles / Year27
Total Citations180

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,119Scopus Q1SCImago Profile
Scopus Coverage:2000-2025
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
0.972

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
1.62

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,028 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations146
3-Year Documents74
Citable Documents59

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate38.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
Pharmacology (medical)Q1
Infectious DiseasesQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Aids Reviews (abbr: AIDS REV, ISSN: 1139-6121) is a peer-reviewed international scholarly journal in the field of Medicine, published by Publicaciones Permanyer in Spain since 1999. The periodical holds a Journal Impact Factor (JIF) of 2.00, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.972 (Q1), an H-index of 64.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 16 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $3,028 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Subscription
Publisher
Publicaciones Permanyer
Publication Language
English
Frequency
Quarterly
Founding Year
1999
Indexing & Databases
SCIEScopusPubMed
Editorial Address
PERMANYER PUBL, MALLORCA, 310, BARCELONA, SPAIN, 00000

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: fbcefd3b-9f41-4dcd-a45f-aa7a302f8c7f
Database Updated: 2026-10-01